p28GANK Prevents Degradation of Oct4 and Promotes Expansion of Tumor-Initiating Cells in Hepatocarcinogenesis
Gastroenterology, 06/04/2012Qian YW et al.
p28GANK(Gankyrin) activates and maintains liver T–ICs in Hepatocellular carcinoma (HCC) by preventing degradation of Oct4. Inhibitors of p28GANK might therefore be developed to inactivate tumor–initiating cells (T–ICs)s and slow tumor progression.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.